141 related articles for article (PubMed ID: 17363571)
1. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers.
Wang Y; Liu DP; Chen PP; Koeffler HP; Tong XJ; Xie D
Cancer Res; 2007 Mar; 67(6):2535-43. PubMed ID: 17363571
[TBL] [Abstract][Full Text] [Related]
2. Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.
Wang Y; Liu D; Chen P; Koeffler HP; Tong X; Xie D
Cancer Res; 2008 Feb; 68(4):1136-43. PubMed ID: 18281489
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
5. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
[TBL] [Abstract][Full Text] [Related]
6. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2.
Park SM; Chae M; Kim BK; Seo T; Jang IS; Choi JS; Kim IC; Lee JH; Park J
Biochem Biophys Res Commun; 2010 Jan; 391(1):926-30. PubMed ID: 19962964
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
Qin YR; Tang H; Xie F; Liu H; Zhu Y; Ai J; Chen L; Li Y; Kwong DL; Fu L; Guan XY
Clin Cancer Res; 2011 Jan; 17(1):46-55. PubMed ID: 21084391
[TBL] [Abstract][Full Text] [Related]
8. Forced expression of the interferon regulatory factor 2 oncoprotein causes polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.
Xie RL; van Wijnen AJ; van der Meijden CM; Stein JL; Stein GS
Cancer Res; 2002 May; 62(9):2510-5. PubMed ID: 11980642
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.
Fu L; Qin YR; Xie D; Hu L; Kwong DL; Srivastava G; Tsao SW; Guan XY
Cancer Res; 2007 Nov; 67(22):10720-6. PubMed ID: 18006814
[TBL] [Abstract][Full Text] [Related]
10. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors.
Egwuagu CE; Li W; Yu CR; Che Mei Lin M; Chan CC; Nakamura T; Chepelinsky AB
Oncogene; 2006 Jun; 25(26):3670-9. PubMed ID: 16462767
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.
Yu C; Chen K; Zheng H; Guo X; Jia W; Li M; Zeng M; Li J; Song L
Carcinogenesis; 2009 May; 30(5):894-901. PubMed ID: 19304953
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
Yi Y; Wu H; Gao Q; He HW; Li YW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Ann Surg Oncol; 2013 Jan; 20(1):267-76. PubMed ID: 22805863
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
16. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
17. Malignant potential of H22 hepatocarcinoma cells increases after recovery from IFN-γ-mediated inhibition.
Gong W; Ma KZ; Liang X; Liu Y; Zhou Q; Zhang J; Chen H; Liu WW
Cell Biol Int; 2011 Jul; 35(7):747-54. PubMed ID: 21261597
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis.
Song Y; Zhao C; Dong L; Fu M; Xue L; Huang Z; Tong T; Zhou Z; Chen A; Yang Z; Lu N; Zhan Q
Carcinogenesis; 2008 Feb; 29(2):307-15. PubMed ID: 18048386
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
20. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
